Company Filing History:
Years Active: 1981
Title: **Raymond Parkinson: Innovator in Antihypertensive Compounds**
Introduction
Raymond Parkinson is an esteemed inventor based in Lowdham, GB, recognized for his contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compounds. His innovative spirit is encapsulated in his patented invention that aims to address hypertension effectively.
Latest Patents
Raymond Parkinson holds a patent for "4-Quinolinones having antihypertensive activity." This invention involves compositions that contain a quinolone compound characterized by a specific formula, which includes several variables such as R1, R2, R3, R4, and R5. The compounds specified are designed to demonstrate antihypertensive activity, making them significant in medical applications aimed at treating high blood pressure.
Career Highlights
He is affiliated with The Boots Company Plc, an influential entity in the pharmaceutical and retail sector. Throughout his career, he has focused on creating innovative solutions that enhance the efficacy of treatments available for hypertension. His dedication to this field has not only furthered the scientific community's understanding of antihypertensive agents but also contributed valuable therapeutic options for patients.
Collaborations
Raymond has collaborated with notable coworkers, including Roy V Davies and James Fraser. These partnerships have fostered a productive environment conducive to research and development, helping to refine and advance the understanding of pharmaceutical innovations within their team.
Conclusion
In summary, Raymond Parkinson stands out as a significant inventor in the realm of antihypertensive compounds. His patent reflects a profound commitment to medical innovation, demonstrating how collaborative efforts in the pharmaceutical industry can lead to meaningful advancements in health care. His work not only highlights his inventiveness but also underscores the importance of ongoing research in improving patient outcomes in the treatment of hypertension.